Peptide blend and stack names show up frequently in real-world conversations, but the names don't always mean the same thing. This section helps decode commonly used names, shows the compounds associated with them, and separates what is known about the individual compounds from evidence for the combination itself.
Community/market names are not automatically standardized formulations; nonstandard composition may vary; component evidence does not establish combination evidence.
Status: Recognized community stack
Wolverine Stack is a community term commonly referring to BPC-157 plus TB-500. Research on the individual compounds or their combination in animal models does not establish effectiveness or safety in humans.
Preclinical combination evidence exists. A 2026 rat Achilles-tendon study directly evaluated BPC-157, TB-500, and their combination. This does not establish human efficacy or safety.
Status: Nonstandard community blend
GLOW is a nonstandard community/market blend name commonly associated with GHK-Cu, BPC-157, and TB-500. The name does not define a standardized scientific or pharmaceutical formulation, and composition or ratios may vary.
No established human clinical evidence was identified for GLOW as a standardized three-component combination. Evidence concerning individual components must not be presented as proof of the blend's effectiveness, safety, or synergy.
Status: Nonstandard community blend
KLOW is a nonstandard community/market blend name commonly associated with GHK-Cu, BPC-157, TB-500, and KPV. The name does not define a standardized scientific or pharmaceutical formulation, and composition or ratios may vary.
No established human clinical evidence was identified for KLOW as a standardized four-component combination. Evidence concerning individual components must not be presented as proof of the blend's effectiveness, safety, or synergy.